Clinical Trial Update: Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 trial update reports results from an investigation of an androgen receptor partial agonist in prostate cancer patients on androgen suppressio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• AR partial agonist (investigational) (androgen receptor partial agonist)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Prostate Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-10-16